Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
EULEXINTM (flutamide) CAPSULES USP
Medication labelWhy this: Advisory · dailymed-prescription
Eulexin™ capsules are indicated for use in combination with LHRH-agonists for the management of locally confined Stage B2-C and Stage D2 metastatic carcinoma of the prostate. Treatment with Eulexin™ capsules and the goserelin acetate implant should start eight weeks prior to initiating radiation therapy and continue during radiation therapy. To achieve benefit from treatment, Eulexin™ capsules should be initiated with the LHRH-agonist and continued until progression.
- generic_name
- flutamide
- product_names
- Flutamide
- ndc
- 80725-600, 80725-600-18
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en